X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1258) 1258
Publication (47) 47
Book Review (8) 8
Book Chapter (1) 1
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (790) 790
humans (611) 611
animals (561) 561
benserazide - pharmacology (556) 556
female (449) 449
rats (390) 390
benserazide - therapeutic use (355) 355
levodopa - therapeutic use (340) 340
parkinson disease - drug therapy (338) 338
middle aged (311) 311
aged (259) 259
levodopa - pharmacology (232) 232
adult (227) 227
benserazide (220) 220
levodopa (214) 214
benserazide - administration & dosage (188) 188
levodopa - administration & dosage (188) 188
drug combinations (187) 187
parkinson's disease (186) 186
drug therapy, combination (172) 172
pharmacology & pharmacy (172) 172
time factors (166) 166
index medicus (164) 164
neurosciences (163) 163
dose-response relationship, drug (153) 153
clinical neurology (144) 144
l-dopa (144) 144
levodopa - adverse effects (137) 137
dopamine (132) 132
dopamine - metabolism (127) 127
antiparkinson agents - therapeutic use (123) 123
aromatic amino acid decarboxylase inhibitors (118) 118
mice (109) 109
hydrazines - therapeutic use (106) 106
hydrazines - pharmacology (100) 100
brain - metabolism (99) 99
parkinsons-disease (96) 96
benserazide - adverse effects (93) 93
motor activity - drug effects (87) 87
5-hydroxytryptophan - pharmacology (85) 85
serotonin - metabolism (83) 83
parkinson disease - physiopathology (77) 77
drug interactions (75) 75
levodopa - pharmacokinetics (75) 75
carbidopa - therapeutic use (74) 74
dopa (74) 74
carbidopa (71) 71
rats, inbred strains (71) 71
double-blind method (68) 68
brain - drug effects (66) 66
corpus striatum - metabolism (65) 65
rats, sprague-dawley (63) 63
carbidopa - pharmacology (62) 62
corpus striatum - drug effects (62) 62
antiparkinson agents - adverse effects (61) 61
behavior, animal - drug effects (61) 61
clinical trials as topic (60) 60
carboxy-lyases - antagonists & inhibitors (57) 57
antiparkinson agents - pharmacology (55) 55
dihydroxyphenylalanine - pharmacology (54) 54
brain chemistry - drug effects (53) 53
delayed-action preparations (53) 53
drug combinations - therapeutic use (53) 53
apomorphine - pharmacology (50) 50
benserazide - pharmacokinetics (50) 50
dopamine agents - pharmacology (49) 49
kinetics (49) 49
pharmacokinetics (49) 49
antiparkinson agents - administration & dosage (48) 48
rats, wistar (48) 48
dopamine - physiology (47) 47
parkinson disease - complications (47) 47
serotonin (46) 46
disease models, animal (45) 45
levodopa - blood (45) 45
levodopa - metabolism (45) 45
blood pressure - drug effects (44) 44
brain (42) 42
treatment outcome (42) 42
norepinephrine - metabolism (41) 41
fenclonine - pharmacology (40) 40
aged, 80 and over (39) 39
drug administration schedule (39) 39
reserpine - pharmacology (39) 39
dopamine agents - therapeutic use (38) 38
neurology (38) 38
parkinson disease - metabolism (38) 38
motor fluctuations (36) 36
chemistry, analytical (35) 35
psychiatry (35) 35
receptors, dopamine - drug effects (35) 35
basal ganglia (34) 34
carbidopa - administration & dosage (34) 34
enzyme inhibitors - pharmacology (34) 34
parkinson’s disease (34) 34
administration, oral (33) 33
cross-over studies (33) 33
drug synergism (33) 33
dyskinesia (33) 33
in vitro techniques (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1105) 1105
French (34) 34
Italian (24) 24
German (22) 22
Russian (17) 17
Chinese (16) 16
Japanese (14) 14
Spanish (14) 14
Polish (4) 4
Dutch (2) 2
Swedish (2) 2
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Clinical Pharmacology, ISSN 0306-5251, 03/2017, Volume 83, Issue 3, pp. 540 - 553
Journal Article
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 06/2019, Volume 10
Prolonged pulsatile administration of Levodopa (L-dopa) can generate L-dopa–induced dyskinesia (LID). Numerous research has reported that continuous dopamine... 
LBPM | β-arrestin2 | L-dopa–induced dyskinesia | Levodopa/benserazide PLGA microsphere | Parkinson’s disease
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 09/2016, Volume 120, pp. 202 - 216
Journal Article
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 07/2014, Volume 40, Issue 2, pp. 2463 - 2470
The activation of inflammatory cascades in the ischemic hemisphere impairs mechanisms of tissue reorganization with consequences for recovery of lost... 
immunomodulation | recovery | inflammation | dopamine | cerebral ischemia | Cerebral ischemia | Inflammation | Dopamine | Immunomodulation | Recovery | RECEPTOR MESSENGER-RNA | INJURY | NEUROSCIENCES | IN-VITRO | CEREBRAL-ARTERY OCCLUSION | IMPROVES FUNCTIONAL RECOVERY | PERIPHERAL-BLOOD LYMPHOCYTES | MURINE EXPERIMENTAL STROKE | ISCHEMIC-STROKE | Antiparkinson Agents - pharmacology | Male | Chemokine CXCL1 - genetics | Benserazide - pharmacology | Infarction, Middle Cerebral Artery - immunology | Interferon-gamma - metabolism | Infarction, Middle Cerebral Artery - metabolism | Interleukins - metabolism | Antiparkinson Agents - therapeutic use | Brain - metabolism | Interleukins - genetics | Infarction, Middle Cerebral Artery - drug therapy | Interferon-gamma - genetics | Chemokine CXCL1 - metabolism | Levodopa - pharmacology | Brain - cytology | Benserazide - adverse effects | Levodopa - therapeutic use | Benserazide - therapeutic use | Rats | Antiparkinson Agents - adverse effects | Rats, Sprague-Dawley | Brain - drug effects | Intercellular Adhesion Molecule-1 - metabolism | Animals | CD8-Positive T-Lymphocytes - drug effects | Intercellular Adhesion Molecule-1 - genetics | Levodopa - adverse effects | Stroke (Disease) | T cells | Brain | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
Journal Article
Journal Article
Journal Article
Journal Article
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 06/2019, Volume 10, p. 660
Prolonged pulsatile administration of Levodopa (L-dopa) can generate L-dopa-induced dyskinesia (LID). Numerous research has reported that continuous dopamine... 
Parkinson's disease | METHYL ESTER/BENSERAZIDE | RECEPTOR | ROPINIROLE | INFUSION | beta-arrestin2 | Levodopa/benserazide PLGA microsphere | LBPM | LEVODOPA-INDUCED DYSKINESIA | DISEASE | L-dopa-induced dyskinesia | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | EXPRESSION | Prevention | Phenols | Genetic vectors | Dopa | Movement disorders
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 6, pp. 1884 - 1899
Although patients with Parkinson's disease show impairments in cognitive performance even at the early stage of the disease, the synaptic mechanisms underlying... 
CA1 area | dementia | synaptic plasticity | dopamine | glutamate | α-synuclein | DOPA-INDUCED DYSKINESIA | COGNITIVE IMPAIRMENT | alpha-synuclein | SUBSTANTIA-NIGRA | NEUROSCIENCES | PREFRONTAL CORTEX | CLINICAL NEUROLOGY | VENTRAL TEGMENTAL AREA | NR2B-CONTAINING NMDA RECEPTORS | CA1 REGION | MOUSE MODEL | DENTATE GYRUS | Synaptosomes - drug effects | Tyrosine 3-Monooxygenase - metabolism | Antiparkinson Agents - pharmacology | Electric Stimulation | Microdialysis - methods | Humans | Biophysical Phenomena - drug effects | Male | Parkinson Disease - drug therapy | Benserazide - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Antiparkinson Agents - therapeutic use | Excitatory Postsynaptic Potentials - physiology | Tritium - metabolism | Long-Term Potentiation - drug effects | Exploratory Behavior - drug effects | Long-Term Potentiation - physiology | Biophysical Phenomena - genetics | alpha-Synuclein - genetics | Dopamine - metabolism | Excitatory Postsynaptic Potentials - genetics | Disease Models, Animal | Levodopa - pharmacology | Parkinson Disease - complications | Parkinson Disease - pathology | Subcellular Fractions - drug effects | Levodopa - therapeutic use | Mice, Inbred C57BL | Benserazide - therapeutic use | Rats | Mice, Transgenic | Long-Term Potentiation - genetics | Mutation - genetics | Subcellular Fractions - metabolism | Sympatholytics - toxicity | Oxidopamine - toxicity | Patch-Clamp Techniques | Animals | Memory Disorders - drug therapy | Memory Disorders - etiology | Analysis of Variance | Synaptosomes - diagnostic imaging | Radionuclide Imaging | Mice | Hippocampus - physiopathology | Parkinson Disease - etiology | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
17.